Genomic Health's Q4 Revenues Increase 27 Percent

Genomic Health said that it achieved its goal of becoming a "self-sustaining business," as it posted strong revenue gains on sales of its OncoType DX breast cancer test.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories